Literature DB >> 2215593

The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.

D L Martin1, K L MacDonald, K E White, J T Soler, M T Osterholm.   

Abstract

BACKGROUND: The frequency of the hemolytic uremic syndrome, characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal failure, is increasing. Although Escherichia coli serotype O157:H7 has been implicated as a causative agent, more information is needed about the basic epidemiology and clinical aspects of this syndrome.
METHODS: We conducted a retrospective population-based study of hemolytic uremic syndrome in Minnesota residents less than 18 years of age from 1979 through 1988 to assess trends in disease occurrence, describe the clinical illness, and identify predictors of disease severity and outcome. We also conducted a case-control study of patients with onsets of illness from 1986 through 1988 to examine risk factors.
RESULTS: One hundred seventeen patients were identified. The mean annual incidence increased from 0.5 case per 100,000 child-years among children less than 18 in 1979 (6 cases) to 2.0 cases per 100,000 in 1988 (26 cases) (P = 0.000004). E. coli O157:H7 was isolated from 13 of 28 patients (46 percent) who had stool specimens submitted for testing. For those who presented with typical hemolytic uremic syndrome, an elevated polymorphonuclear-leukocyte count on hospital admission, a shorter duration of prodrome, and the presence of bloody diarrhea were predictive of severe disease. In the case-control study, the patients were more likely to attend large daycare centers (more than 50 children) than were the controls (odds ratio, 10.2; P = 0.03), suggesting that day-care attendance may be a risk factor. On the basis of the population-attributable risk, however, this factor could account for no more than 16 percent of the cases.
CONCLUSIONS: This study provides evidence for an increase in the incidence of hemolytic uremic syndrome, which is probably related to an increased incidence of E. coli O157:H7 infections. Hemolytic uremic syndrome has become an important pediatric and public health problem.

Entities:  

Mesh:

Year:  1990        PMID: 2215593     DOI: 10.1056/NEJM199010253231703

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  40 in total

1.  Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective.

Authors:  Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-12-13       Impact factor: 3.714

2.  Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli.

Authors:  T J Novicki; J A Daly; S L Mottice; K C Carroll
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections.

Authors:  Sue C Kehl
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 4.  Infectious diseases and AIDS.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

5.  Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran.

Authors:  Francesco Rodeghiero
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

6.  Clinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran.

Authors:  Mehran Karimi; Ameneh Sabzi; Flora Peyvandi; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

7.  Point: Should all stools be screened for Shiga toxin-producing Escherichia coli?

Authors:  Mario J Marcon
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

8.  Isolation of verotoxin-producing Escherichia coli O-rough:K1:H7 from two patients with traveler's diarrhea.

Authors:  J Vila; M Vargas; J Ruiz; F Gallardo; M T Jimenez de Anta; J Gascón
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

9.  Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples.

Authors:  Patrick J Gavin; Lance R Peterson; Anna C Pasquariello; Joanna Blackburn; Mark G Hamming; Kuo J Kuo; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome?

Authors:  Rachel Harwood; David Wilkinson; Shweta Ramkumar; Gillian Humphrey
Journal:  Pediatr Surg Int       Date:  2015-11-17       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.